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ABSTRACT
A long RNA oligomer, a 110mer with the sequence
of a precursor-microRNA candidate, has been
chemically synthesized in a single synthesizer run
by means of standard automated phosphoramidite
chemistry. The synthetic method involved the
use of 2-cyanoethoxymethyl (CEM), a 20-hydroxyl
protecting group recently developed in our labora-
tory. We improved the methodology, introducing
better coupling and capping conditions. The overall
isolated yield of highly pure 110mer was 5.5%. Such
a yield on a 1-kmol scale corresponds to 1mg of
product and emphasizes the practicality of the CEM
method for synthesizing oligomers of more than
100nt in sufficient quantity for biological research.
We confirmed the identity of the 110mer by matrix-
assisted laser desorption/ionization time-of-flight
(MALDI-TOF) mass spectrometry, as well as HPLC,
electrophoretic methods, and RNase-digestion
experiments. The 110mer also showed sense-
selective specific gene-silencing activity. As far as
we know, this is the longest chemically synthesized
RNA oligomer reported to date. Furthermore, the
identity of the 110mer was confirmed by both
physicochemical and biological methods.
INTRODUCTION
The discovery of RNA interference (RNAi) (1), a speciﬁc
gene-silencing mechanism mediated by small RNA
molecules such as small interfering RNA (siRNA) (2)
and microRNA (miRNA) (3), has had a major impact on
research in the life sciences, and, in recent years, great
advances have been made in our understanding of these
and other kinds of non-coding RNA (4,5). Application to
basic research is exempliﬁed by the work of Siolas et al.
(6) on short hairpin RNA (shRNA) and Amarzguioui
et al. (7) on siRNA. RNA is also expected to play an
important role in drug discovery, and several candidate
small RNA molecules have already entered clinical
trials (8). As a result of the increased demand for RNA
for use as research reagents and potential therapeutic
agents, more importance than ever is being attached to
practical new methods in the chemical synthesis of RNA.
From the earliest days of research on RNA synthesis,
it has been appreciated that the single most demanding
problem is the selection of a suitable protecting group
for the 20-hydroxyl function of the ribose of the RNA.
This protecting group must be stable throughout the
solid-phase synthetic cycle, yet it must be readily
removable under mild conditions (9). t-Butyldimethylsilyl
(TBDMS) (10) is a popular 20-hydroxyl protecting group
whose phosphoramidite is commercially available. While
the TBDMS method gives RNA of reasonable purity in
reasonable yield, both yield and purity are sensitive to
small changes in the synthetic conditions. Furthermore,
the TBDMS group is associated with relatively long
coupling times (11) and insuﬃciently high coupling yields
(12), though improvements based on the use of more
powerful activators or less bulky 20-hydroxyl protecting
groups have been proposed (12). To resolve these pro-
blems, three new protecting groups, bis(2-acetoxyethyl-
oxy)methyl (ACE) (13), triisopropylsilyloxymethyl
(TOM) (14), and more recently t-butyldithiomethyl
*To whom correspondence should be addressed. Tel: þ81-29-850-6243; Fax: þ81-29-850-6217; Email: t.ohgi@po.nippon-shinyaku.co.jp
 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.(DTM) (15), have been developed. Though such protect-
ing groups represent major improvements in the synthesis
of RNA oligonucleotides (16), however, they still leave
something to be desired in their practical application.
Thus, the synthesis of ACE-amidites is relatively complex
(9) (though they are now commercially available), and
automated synthesizers require special modiﬁcation for
use with them because of the incompatibility of glass
materials with triethylamine trihydroﬂuoride, the 50-
desilylation reagent. TOM-protected oligonucleotides,
meanwhile, are not readily amenable to routine analysis
and puriﬁcation by HPLC because of the hydrophobic
nature of the silyl group. Finally, DTM-amidites, parti-
cularly the G amidite, are somewhat unstable in acetoni-
trile solution (15).
Chemical rather than enzymatic synthesis of RNA is
desirable because it avoids the various errors and
ineﬃciencies associated with in vitro transcription by T7
RNA polymerase (17). Chemical synthesis is also desirable
for the ease of incorporation of modiﬁed nucleosides,
which is important for studies of RNA structure and
function. For example, site-speciﬁc disulphide cross-links
have been used as probes of RNA tertiary structure (18).
For such purposes, it is useful if the synthetic method can
be extended to the eﬃcient production of very long RNA
oligomers. However, despite the advances that have been
made in automated solid-phase synthesis, the production
of longer RNA oligomers is still diﬃcult and time-
consuming. Previously synthesized RNA oligonucleotides
up to 77nt long have been generally restricted to tRNA
(19–23), although there is also an example of the synthesis
of an 84mer RNA oligonucleotide by the TOM method
(14). Sometimes it is necessary to assemble shorter
oligoribonucleotides to the full-length RNA by enzymatic
ligation, as in the synthesis of Ascaris suum tRNA
Met by
Ohtsuki et al. (24).
Therefore, many points remain to be resolved in the ﬁeld
of RNA synthesis, and because of the increased demand
for RNA there is a need for a radically improved synthetic
method that would allow RNA synthesis to be carried out
as eﬃciently as DNA synthesis, scaled up to the levels now
obtained in DNA synthesis, and applied to the production
of very long RNA oligomers. To meet this need, we have
developed an achiral 20-hydroxyl protecting group,
2-cyanoethoxymethyl (CEM), that has low steric hin-
drance and that can be completely removed under mild
conditions (25). CEM chemistry is also compatible with
standard, unmodiﬁed DNA synthesizer equipment.
In the present study, we have further developed the
CEM method by signiﬁcantly improving the capping
and coupling conditions. To verify the potential of the
improved method, we have undertaken the total chemical
synthesis of a very long RNA oligomer. To the best of our
knowledge, there has been no report of the chemical
synthesis of an RNA oligomer longer than 100nt. Here,
we describe the synthesis of a 110mer precursor-miRNA
(pre-miRNA) candidate by our improved new method. In
contrast to previously synthesized long RNA oligonucleo-
tides, which have generally been characterized by
biochemical or biological means alone, we have conﬁrmed
the identity of the product by physicochemical methods
as well as through assessing its biological activity by
measuring its gene-silencing eﬀect.
MATERIALS AND METHODS
General methods
Column chromatography was performed with Wako silica
gel C-200, and TLC was carried out on Merck Silica gel 60
F254 TLC aluminium sheets. Analytical HPLC was
performed on Shimadzu HPLC systems equipped with
DNAPac PA100 (4 250mm, Dionex) or PLRP-S 300A ˚
(4.6 150mm; Polymer Laboratories, Church Stretton,
UK) columns, preparative reverse-phase column chroma-
tography (DMTr-on mode) was performed with PLRP-S
300A ˚ resin packed in 20 110mm columns, and semipre-
parative anion-exchange HPLC (DMTr-oﬀ mode) was
performed on a DNAPac PA100 (9 250mm) column.
Capillary gel electrophoresis was carried out on a P/ACE
MDQ Molecular Characterization System with the ssDNA
100-RKit(BeckmanCoulter).UVspectrawererecordedon
a Hitachi U-3210 spectrometer, and
1H,
13C, and
31P NMR
spectra on a Bruker DRX500 or DPX300 spectrometer.
Chemical shifts are reported relative to tetramethylsilane
andreferencedtotheresidualprotonsignalofthefollowing
deuterated solvents: CDCl3 (7.25p.p.m.) or DMSO-d6
(2.50p.p.m.) for
1H NMR, CDCl3 (77.0p.p.m.) or DMSO-
d6 (39.5p.p.m.) for
13C NMR, and external 85% phos-
phoricacid for
31PNMR. Matrix-assisted laser desorption/
ionization time-of-ﬂight (MALDI-TOF) mass spectra were
obtained with a Bruker Autoﬂex spectrometer (Bruker
Daltonics, Billerica, MA). Reagents and solvents were
purchased from commercial suppliers and used without
further column chromatography. Anhydrous solvents were
purchased from Kanto Kagaku (Tokyo, Japan), and
tetrabutylammonium ﬂuoride (TBAF) was purchased
from Nacalai Tesque (Kyoto, Japan).
Synthesis ofCEM-phosphoramidites
Full experimental procedures describing the synthesis
of the CEM-phosphoramidites (henceforth termed
‘CEM-amidites’) are available in Supplementary Data.
Synthesis of110mer RNA
The long oligomer selected for synthesis was the 110mer pre-
miRNA hairpin candidate 50-UGCUCGCUCA GCUGA
UCUGU GGCUUAGGUA GUUUCAUGUU GUUG
GGAUUG AGUUUUGAAC UCGGCAACAA GAAAC
UGCCU GAGUUACAUC AGUCGGUUUU CGUCG
AGGGC-30 (miR-196a-2 precursor; listed in miRBase) (26).
Using the CEM-amidites prepared as described in
Supplementary Data, we synthesized the 110mer RNA
on an Applied Biosystems Expedite Model 8909 nucleic
acid synthesizer. In HPLC analyses and preparative
puriﬁcation, the following solvent systems were used: for
reverse-phase HPLC, buﬀer A [5% acetonitrile in 50mM
triethylammonium acetate (TEAA), pH 7] and buﬀer
B (90% acetonitrile in 50mM TEAA, pH 7); and for
anion-exchange HPLC, buﬀer C (10% acetonitrile in
25mM Tris-HCl, pH 8.0) and buﬀer D (10% acetonitrile
containing 700mM NaClO4 in 25mM Tris-HCl,
pH 8.0). For preparative reverse-phase column
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with PLRP-S 300A ˚ resin (50–70mm), and elution was
carried out with a gradient of buﬀer A and buﬀer B. For
semipreparative anion-exchange HPLC (DMTr-oﬀ
mode), elution was carried out with a gradient of buﬀer
C and buﬀer D. Dialysis was carried out with a Spectra/
Pore membrane (molecular weight cut-oﬀ, 1000;
Spectrum Laboratories, Laguna Hills, CA). Nuclease P1
was from Yamasa (Chiba, Japan), and alkaline phospha-
tase was from Promega (Madison, WI).
Analysisof110merRNAbyMALDI-TOFmassspectrometry
of RNase cleavage products
For RNase T1 digestion, RNA (60 pmol) was incubated
with 0.3 U RNase T1 (Ambion, Austin, TX) in 50mM
Tris-HCl, pH 7.5, containing 1mM EDTA and 25mg/ml
GpA in a total reaction volume of 30mla t3 7 8C for 18h.
For MazF digestion, RNA (60 pmol) was incubated with
213 U MazF (Takara, Otsu, Japan) in 20mM sodium
phosphate, pH 6.0, containing 0.05% Tween-20 in a total
reaction volume of 30mla t3 7 8C for 1h. The digestion
products were puriﬁed by phenol/chloroform extraction
and ZipTip C18 reverse-phase microcolumns (Millipore,
Bedford, MA). MALDI-TOF mass spectra were acquired
in positive-ion mode with a matrix solution consisting
of 10mg/ml 3-hyroxypicolinic acid and 1mg/ml diammo-
nium citrate. The potential for linear acceleration was
19kV, and the potential for reﬂector acceleration
was 20kV. The IS/2 potential was set at 16.6kV.
Ion extraction was delayed by 130ns, and 240 shots
were accumulated for each sample.
Compositionalanalysisof110merRNAbynucleasedigestion
RNA oligomer (20 ODU at 260nm) was incubated with
nuclease P1 (0.3 units) at 378C for 24h. Then, alkaline
phosphatase (3 units) and buﬀer (50mM Tris-HCl,
pH 9.3, containing 1mM MgCl2, 0.1mM ZnCl2, and
1mM spermidine, all at ﬁnal concentrations) were added
to give a total volume of 115ml, and the mixture was
incubated at 378C for 2 days. The reaction mixture
was then analyzed by HPLC.
Plasmid construction
Reporter plasmids pHOXB-Luc and pHOXB-Luc-
antisense were constructed by inserting DNA duplex
into the Xba I site of the luciferase reporter vector
pGL4.13[luc2/SV40] (Promega) according to the suppli-
er’s protocol. The sequences of the inserted fragments
were as follows: pHOXB-Luc sense, 50-CTAGATTGTG
CTAAGTTCTC CCAACAACAT GAAACTGCCT
ATTCACGCCG TAATTT-30; pHOXB-Luc antisense,
50-CTAGAAATTA CGGCGTGAAT AGGCAGTTTC
ATGTTGTTGG GAGAACTTAG CAGAAT-30;
pHOXB-Luc-antisense sense, 50-CTAGAAATTA
CGGCGTGAAT AGGCAGTTTC ATGTTGTTGG
GAGAACTTAG CAGAAT-30; and pHOXB-Luc-anti-
sense antisense, 50-CTAGATTGTG CTAAGTTCTC
CCAACAACAT GAAACTGCCT ATTCACGCCG
TAATTT-30.
Cellculture andtransfection
Human embryonic kidney derived cell line G3T-hi was
purchased from Takara and maintained in Dulbecco’s
modiﬁed Eagle’s medium (Sigma) supplemented with 10%
foetal bovine serum at 378C in a humidiﬁed atmosphere.
Transfections with plasmid DNA and/or RNA were
performed with FuGENE 6 transfection reagent (Roche,
Indianapolis, IN) according to the supplier’s instructions.
Luciferase reporter assay
G3T-hi cells (1 10
4) were seeded on a 96-well plate and
incubated for 20h. Reporter plasmid DNA (10ng) and
eﬀector RNA (30 or 100nM each at ﬁnal concentration)
were transfected by means of FuGENE 6. Forty-eight
hours after transfection, luciferase activity was measured
with the Steady-Glo Luciferase Assay System (Promega)
according to the supplier’s protocol. Sense and antisense
22-nt single-stranded RNAs (Japan BioService, Saitama,
Japan) were annealed in distilled water for use as mature
miRNA duplex. Luminescence intensity was measured
with a microplate scintillation and luminescence counter
(Packard, Meriden, CT), and luciferase activity was
calculated relative to the basal activity expressed by
pHOXB-Luc in the absence of eﬀector RNA.
RESULTS AND DISCUSSION
Synthesis of CEM-amidites
There was room for improvement in our previously
reported method of synthesizing the monomer CEM-
amidites (25). In that method, we started with the
50-O-DMTr compound and alkylated the 20-hydroxyl
group to give intermediate 4. However, because we could
not achieve selective alkylation of the 20-hydroxyl group,
the concurrently obtained 30-O-CEM derivative had to be
removed by column chromatography. Therefore, we
sought an improved synthetic route for the CEM-amidites
that could be carried out simply on a large scale, and we
establishedtheroutesshowninFigure1.Intheseroutes,we
introduce the CEM group into a 30,50-protected nucleoside
(1a–d). With 2-cyanoethyl methylthiomethyl ether as the
alkylating agent and N-iodosuccinimide (NIS) as the
activator, the alkylation of the uridine, cytidine, and
guanosine derivatives 1a–c proceeded eﬃciently at low
temperature ( 458C). In the case of the adenosine
derivative 1d only, the eﬃciency of alkylation was low.
Therefore, compound 2d was produced by activating the
nucleoside through methylthio derivative 6. Using these
routes, we were able to synthesize all of the CEM-amidites
with selective alkylation of the 20-hydroxyl group with
relative ease on a preparative scale. We are currently
working on the further improvement of this method.
Synthesis, deprotection and purification of 110merRNA
The RNA was synthesized on a 0.8-mmol scale by the
phosphoramidite method modiﬁed for CEM chemistry.
The conditions of the synthetic cycle are shown in Table 1.
Trichloroacetic acid in dichloromethane was used as the
detritylation reagent. For the coupling reaction, amidites
Nucleic Acids Research, 2007, Vol. 35,No. 10 3289were used as 0.075M solutions in acetonitrile, and
5-benzylmercaptotetrazole (BMT) was used as the acti-
vator instead of the 5-ethylthio-1H-tetrazole (ETT) used
in the original method (25). BMT was adopted as the
activator after a trial of about a dozen activators in the
synthesis of short oligomers. The alternative activators
tried included 4,5-(dicyano)imidazole, benzimidazolium
triﬂate, 1H-tetrazole, and pyridinium triﬂuoroacetate.
In addition to being a very powerful activator, BMT
was found to give the best coupling yields and the
cleanest crude product. A mixture of phenoxyacetic
anhydride (Pac2O) in THF and 2-dimethylaminopyridine
(2-DMAP), N-methylimidazole (NMI), and 2,6-lutidine
in THF was used as the capping reagent to suppress
the formation of 2,6-diaminopurine (2,6-DAP). [In the
original method (25), NMI and pyridine were used as
the base catalysts.] The oxidizing agent was 0.1M
iodine in THF/pyridine/water. Commercially available
controlled-pore glass (CPG) with a pore size of 2000A ˚
derivatized with N
4-benzoyl-20-O-TBDMS-ribocytidine as
the leader nucleoside was used as the solid support instead
of 500-A ˚ or 1000-A ˚ CPG. Although the leader nucleoside
bears a diﬀerent base-protecting group and 20-hydroxyl
protecting group, their removal from a single residue at
the 30 end of the oligomer presented no problem under the
conditions of the CEM method. A 2000-A ˚ resin was used
because, in our experience, a large-pore resin gives better
yields in the synthesis of very long oligomers. Thus, in
several respects, as described above, the synthetic condi-
tions have been improved over those used in the original
method (25).
After synthesis, the RNA was puriﬁed on a 0.7-mmol
scale by two rounds of HPLC (DMTr-on and DMTr-oﬀ
modes). First, the DMTr-on CPG solid support was
treated with 50% triethylamine in acetonitrile to remove
the cyanoethyl protecting group from the phosphate
groups. Cleavage from the CPG solid support and
removal of the base-protecting group was then carried
out by treatment with a mixture of 28% ammonia solution
and EtOH [3:1 (v/v)] for 24h at 358C. Removal of the
phosphate-protecting and base-protecting groups can in
principle be carried out in a single step. However, a minor
side-reaction, adduct formation by the cyanoethyl group,
may become signiﬁcant in the synthesis of very long
oligomers. To avoid this possibility, the two-step protocol
was used. In the next step, the CEM protecting group was
Figure 1. Synthesis of CEM-amidites. (i) 2-cyanoethyl methylthiomethyl ether, molecular sieves 4A (MS 4A), NIS, CF3SO3H, THF,  458C;
(ii) DMSO, acetic anhydride, acetic acid; (iii) 3-hydroxypropionitrile, MS 4A, NIS, CF3SO3H, THF,  458C; (iv) NH4F, MeOH, 508Co r
TEA 3HF, THF, 458C; (v) 4,40-dimethoxytrityl chloride, THF, pyridine, MS 4A, room temperature; (vi) diisopropylammonium tetrazolide,
bis(N,N-diisopropylamino) cyanoethylphosphite, CH3CN, 408C.
Table 1. Synthetic conditions for 110mer RNA
Step Operation Reagent Time (s)
1 Deblocking 4% CCl3COOH in CH2Cl2 60
2 Coupling 0.075M amidite in CH3CNþ0.25M
BMT in CH3CN
150
3 Capping 0.1M Pac2O in THFþ6.5% 2-DMAP,
2% NMI and 10% 2,6-lutidine in THF
170
4 Oxidation 0.1M I2 in THF/pyridine/water (7/1/2) 5
5 Capping 0.1M Pac2O in THFþ6.5% 2-DMAP,
2% NMI and 10% 2,6-lutidine in THF
30
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0.5% nitromethane as an acrylonitrile scavenger, for 5h at
room temperature to remove the CEM protecting group.
To achieve smooth and complete deprotection, the TBAF
solution needs to be dried with molecular sieves 4A before
use. After quenching the deprotection reaction mixture
with Tris-HCl buﬀer, the crude RNA was obtained by
EtOH precipitation.
Capillary gel electrophoresis and HPLC of the crude
product after the removal of all protecting groups showed
a single main peak with only tiny amounts of shorter
products, though HPLC did resolve a couple of impurity
peaks corresponding to long products (Supplementary
Figures 1 and 2). The RNA was puriﬁed by reverse-phase
column chromatography (PLRP-S 300A ˚ ) in the DMTr-on
mode, and the DMTr-on product was then treated with
80% AcOH solution to remove the DMTr group. DMTr-
oﬀ puriﬁcation was carried out by semipreparative HPLC
(DNAPac PA100), and pure fractions were desalted by
dialysis. The desired RNA product was obtained in good
overall yield (5.5%; 41.5 ODU, 38.2nmol).
In a comparison of the synthesis of a mixed-base 55mer
by the CEM and the TBDMS methods, both with BMT as
the activator, the HPLC proﬁles of the crude product were
quite diﬀerent. The CEM proﬁle shows a single major
peak with only tiny amounts of shorter impurities (25),
while the TBDMS proﬁle showed substantial amounts of
shorter impurities (data not shown). Furthermore, though
the CEM and TOM methods were not compared under
the same conditions in the synthesis of the same sequence,
published data on the TOM method shows substantial
amounts of shorter impurities on capillary gel electro-
phoresis of the crude product [84mer; Ref.(14)], whereas
the CEM method showed only tiny amounts (82mer;
unpublished data).
While this study was in progress, another 20-hydroxyl
protecting group, 2-(4-tolylsulphonyl)ethoxymethyl
(TEM), was reported by Zhou et al. (27). So far, however,
only the synthesis of a 38mer uridine homo-oligomer
and mixed-base oligomers of up to 21 nucleotides has been
described. In the CEM method, meanwhile, despite
the loss of 55% of CEM during ammonia treatment,
no chain cleavage is observed (25), and no limitation
in the use of the CEM method for the synthesis of
RNA oligomers of up to 110nt was noted in the present
study.
Physicochemical identification of110mer RNA
Reverse-phase and anion-exchange HPLC and capillary
gel electrophoresis analysis of the ﬁnal product showed
only a single peak (Figure 2A–C), conﬁrming the purity of
the RNA obtained. Polyacrylamide gel electrophoresis
analysis (Figure 2D) is consistent with the synthesis of a
110mer. We also conﬁrmed the structure of the product by
mass spectrometry. A MALDI-TOF mass-spectrometric
analytical method is now available to conﬁrm the
molecular weight of oligonucleotides, though the analysis
of oligomers longer than 50nt is reported to be diﬃcult
(28). Therefore, we carried out MALDI-TOF mass-
spectrometric analysis of the partial-digestion products
of MazF, an endonuclease that cleaves speciﬁcally at
ACA sequences (29). The highest m/z peak corresponds to
the undigested RNA oligomer, and the small diﬀerence
between the calculated and observed m/z values is
consistent with a length of precisely 110nt (Figure 3).
We also observed peaks corresponding to the expected
44mer, 66mer and 85mer fragments. The smallest expected
fragment, a 25mer, was observed in other digests (data not
shown).
To check the identity of the 110mer by an independent
method, we digested it with RNase T1, an endonuclease
that cleaves speciﬁcally on the 30 side of G, leaving a
30-phosphate or 20,30-cyclic phosphate, and analyzed the
fragments by mass spectrometry. Except for monomers
and dimers, which were hard to distinguish among the
noise of the spectrum, all of the expected fragments were
identiﬁed (Figure 4A and B and Table 2), consistent with
the synthesis of the target 110mer. RNase T1 digestion
yielded pairs of fragments with 30-phosphate or 20,30-cyclic
phosphate, diﬀering in molecular weight by 18. For
example, fragments L and L0 (AACUCG; sequence 13,
Table 2) yielded observed molecular weights of 1939.5
(fragment L; calcd 1939.2) and 1921.5 (fragment L0; calcd
1921.2). All other fragments were similarly identiﬁed.
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Figure 2. HPLC and electrophoretic analysis of puriﬁed 110mer RNA.
(A) A PLRP-S 300A ˚ HPLC reverse-phase column was operated at
a ﬂow rate of 1ml/min and maintained at a temperature of 808C.
The solvent system was buﬀers A and B, and the RNA was eluted with
a linear gradient from 0 to 50% buﬀer B in 20min. (B) A DNAPac
PA100 HPLC anion-exchange column was operated at a ﬂow rate of
1.5ml/min and maintained at a temperature of 708C. The solvent
system was buﬀers C and D, and the RNA was eluted with a linear
gradient from 5 to 50% buﬀer D in 20min. (C) Capillary gel
electrophoresis. (D) Polyacrylamide gel electrophoresis. The synthetic
RNA was analyzed on a 5% polyacrylamide gel and stained with the
cyanine dye SYBR Green II.
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110 mer-pre-miRNA: peak 1
(calcd m/z: 35330)
Fragment 1: peak 2
(calcd m/z: 27339)
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(calcd m/z: 14122) Fragment  2: peak 3
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Figure 3. Mass-spectrometric analysis of MazF cleavage products of the 110mer RNA. (A) Sequence of 110mer and the predicted cleavage products.
(B) MALDI-TOF mass spectrum of MazF cleavage products.
3292 Nucleic Acids Research, 2007, Vol. 35, No. 10Nucleoside-composition analysis of110mer RNA by
nuclease digestion
The RNA was treated with nuclease P1 and then alkaline
phosphatase, and the digestion products were analyzed by
HPLC (Figure 5). With the exception of 2,6-DAP noted
below, no modiﬁed ribonucleosides were observed, show-
ing that complete removal of the CEM protecting groups
and base-protecting groups had been achieved.
Furthermore, no dimers (20,50-phosphodiester-linked
dinucleotides resulting from internucleotide migration or
branched structures resulting from side reactions occur-
ring during the condensation cycle) were observed. In our
previously reported CEM synthetic method (25), the
formation of 2,6-DAP was not observed in the synthesis
of oligomers up to 55nt in length. However, with
continued repetition of the capping step during the
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Figure 4. Mass-spectrometric analysis of RNase T1 cleavage products
of the 110mer RNA. (A) MALDI-TOF mass spectrum of RNase T1
cleavage products. The inset shows an expanded view of the mass range
1860–1980. (B) Sequence of fragments produced by RNAse T1
digestion. The numbers shown represent the entry numbers of the
fragments given in Table 2. Cleavage occurs on the 30 side of G, and
each number is placed at the G residue where cleavage occurs.
Table 2. Sequences and masses of fragments produced by RNase T1 digestion
30-Phosphate 20,30-Cyclic phosphate
Entry number
a Sequence (50!30) Peak Calculated mass Observed mass Peak Calculated mass Observed mass
1 UG A 670.4 N.I.
b A0 652.4 N.I.
2 CUCG B 1280.8 1280.9 B0 1262.8 1262.9
3 CUCAG C 1610.0 1610.2 C0 1592.0 N.D.
c
4 CUG D 975.6 975.6 D0 957.6 957.6
5 AUCUG E 1611.0 1611.2 E0 1593.0 1593.2
6 CUUAG E 1611.0 1611.2 E0 1593.0 1593.2
7 UAG F 999.6 999.7 F0 981.6 N.D.
8 UUUCAUG G 2223.3 2223.6 G0 2205.3 2205.6
9 UUG H 976.6 N.I. H0 958.6 N.I.
10 AUUG I 1305.8 1306.0 I0 1287.8 1287.9
11 AG J 693.5 N.I. J0 675.5 N.I.
12 UUUUG K 1588.9 1589.1 K0 1570.9 N.D.
13 AACUCG L 1939.2 1939.5 L0 1921.2 1921.5
14 CAACAAG M 2291.4 2291.8 M0 2273.4 2273.7
15 AAACUG N 1963.2 1963.5 N0 1945.2 1945.5
16 CCUG B 1280.8 1280.9 B0 1262.8 1262.9
17 UUACAUCAG O 2880.7 2881.1 O0 2862.7 N.D.
18 UCG D 975.6 975.6 D0 957.6 957.6
19 UUUUCG P 1894.1 1894.4 P0 1876.1 1876.4
aThe entry numbers correspond to the numbered fragments shown in Figure 4B.
bN.I., not identiﬁed.
cN.D., not detected.
Figure 5. HPLC analysis of enzymatically digested 110mer RNA.
A Develosil ODS-UG-5 reverse-phase column (4.6 250mm) was
operated at a ﬂow rate of 1ml/min and maintained at a temperature
of 408C. The buﬀer was 50mM KH2PO4, pH 3.0, with H3PO4/MeOH,
20:1 (v/v).
Nucleic Acids Research, 2007, Vol. 35,No. 10 3293synthesis of very long oligonucleotides, the formation
of 2,6-DAP due to modiﬁcation of G became detectable.
(When pyridine or 4-dimethylaminopyridine (4-DMAP)
is used in the capping reagent, displacement of the
O
6-phosphate triester adduct on G leads to the formation
of 2,6-DAP after ammonia treatment during deprotection.
When 2,6-lutidine or 2-DMAP is used instead, this dis-
placement reaction is hindered by the presence of two
methyl groups or a dimethylamino group ortho to the
pyridine-ring nitrogen.) Though it was possible to
completely suppress the formation of 2,6-DAP by using
Pac2O/2-DMAP/2,6-lutidine as the capping reagent,
under these conditions the eﬃciency of the capping
reaction was slightly reduced, which is a signiﬁcant
disadvantage in the synthesis of very long oligomers. It
was therefore decided to ﬁnd compromise conditions in
which very low levels of 2,6-DAP formation could be
tolerated for the sake of a high capping eﬃciency. By
adjusting the ratio of NMI to 2-DMAP in the capping
reagent, we could achieve a very high capping eﬃciency,
though not quite perfect suppression of 2,6-DAP
formation.
Biological activity of110mer RNA
To assess the biological activity of the chemically
synthesized 110mer pre-miRNA candidate, we measured
its speciﬁc gene-silencing eﬀect. Generally, small dsRNAs
suppress the expression of their target genes, whose
mRNA possess sequences complementary to those of the
small RNAs, by causing cleavage of the mRNA or
inhibiting its translation (30). To determine the silencing
eﬀect of miRNAs, we constructed a reporter assay system.
The sequence of the RNA synthesized was that of pre-
miR-196a-2, so we used a reporter gene whose expression
can be regulated by miR-196a. There is predicted to be a
miR-196a target sequence in the 30 untranslated region of
human homeobox gene b-8 (HOXB8), and HOXB8
expression has been suggested to be regulated by miR-
196a (31). We inserted DNA duplex corresponding to this
target sequence and its ﬂanking region into a luciferase-
expressing reporter plasmid. In this system, a silencing
eﬀect by miR-196a results in a reduction in luciferase
expression.
Transfection with chemically synthesized 110mer RNA
decreased the expression of the target gene about as
eﬀectively as 22mer mature miR-196a RNA duplex
(Figure 6A). The suppression of luciferase activity by
110mer RNA is considered to have resulted from the
inhibition of luciferase protein expression, possibly at the
transcriptional or translational level. Because pre-miRNA
has to be processed to a smaller size to exert its
gene-silencing eﬀect, we conclude that our synthetic
110mer RNA was successfully processed and that the
mature miRNA derived from the 110mer functioned as a
silencing miRNA.
Although the guide (antisense) strand of an siRNA
molecule is normally speciﬁcally incorporated into the
RNA-induced silencing complex (RISC), it sometimes
happens that the passenger (sense) strand is incorporated,
giving rise to oﬀ-target eﬀects (32,33). A pre-miRNA
molecule, in contrast, is expected to interact more
speciﬁcally with RISC, allowing more speciﬁc incorpora-
tion of the antisense strand and exclusion of the sense
strand during processing of the pre-miRNA, with result-
ing preferential cleavage of the target mRNA (32–34). In
the case of pre-miR-196a, we found that the silencing
eﬀect against the sense target was about twice as strong as
that against the antisense target, whereas 22mer mature
miR-196a showed about the same silencing eﬀect against
both targets (Figure 6B). The observation of an equal
silencing eﬀect against the sense and antisense target
mRNA by the 22mer is probably due to the sequences
at the ends, which might prevent preferential incorpora-
tion of the guide strand. The 110mer pre-miRNA,
therefore, showed a strand selectivity in the gene-silencing
eﬀect that was not shown by the mature miRNA. This
observation supports the idea that the use of pre-miRNA
instead of mature miRNA can be useful in gene silencing
to confer selectivity of the antisense strand and to reduce
the likelihood of oﬀ-target eﬀects.
CONCLUSIONS
We have devised an improved method for the synthesis of
CEM-amidites that is suitable for large-scale synthesis.
We have also improved the conditions for the solid-phase
synthesis of oligomers. With our improved CEM method,
it is possible to synthesize very long oligomers that have
until now been extremely diﬃcult to synthesize. We have
demonstrated the potential of the method by synthesizing,
for the ﬁrst time, an RNA oligomer longer than 100nt.
The 110mer we synthesized was produced by total
chemical synthesis in a single synthesizer run, without
the need for enzymatic ligation of separately synthesized
fragments. Its structure was conﬁrmed by physicochemical
methods, including mass spectrometry, and it was also
shown to have biological activity. To our knowledge, it is
by far the longest chemically synthesized RNA whose
structure has been determined by physicochemical meth-
ods. We believe that our new improved CEM method is
suﬃciently practical to become the standard RNA
synthetic method, with special application to the synthesis
of very long RNA oligomers.
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